Friday, February 7
Lawrence Business Magazine LLC
Lawrence Business Magazine LLC
2014 Fourth Quarter - New & Growing Technology

CritiTech & Deciphera

By on 165 Comments
INNOVATION: DEVELOPING NEW DRUGS AND NEW DRUG DELIVERY SYSTEMS IN LAWRENCE
| 2014 Q4 | story by LIZ WESLANDER    | photos by STEVEN HERTZOG |
Tech

Deciphera lab

Hidden in plain sight among unassuming buildings in downtown and north Lawrence are two high-tech biotechnology companies that are working on innovative cancer treatments that could be available on the market in the future.

CritiTech, a Lawrence born-and-bred drug development company, operates both its labs and business offices in a space along E. 1450 Rd just north of downtown. Deciphera, with its business headquarters in Boston, Mass. has biology and chemistry labs located on the 600 block of Massachusetts Street- right across from the Free State Brewery.

Daniel Flynn, the CSO and Founder of Deciphera Pharmaceuticals, received his Ph.D. in medicinal chemistry at the University of Kansas. Flynn said that when he established Deciphera in 2003, he could have located the company’s research labs anywhere in the country. He chose Lawrence.

Tech

CritiTech lab equipment

“I wasn’t wooed here, I came voluntarily.” Flynn said. “Even back 10 years ago there was a beginning of a desire from the thought leaders of the city wanting to bring Lawrence forward as a regional biotech hub. I wanted to be a part of that.”

Deciphera’s labs were originally located at KU’s Life Science Research Laboratories, at 1501 Wakarusa. In 2011, they moved to their downtown location.

“It’s surprising that we would have a research lab above Chico’s and the Gap, but we worked with city commission to make them comfortable with being us downtown,” Flynn said. “Lawrence is a wonderful town to work in. At least a third of our hires have been KU graduates or KU-affiliated. We have had no problem tapping into the human resources that have been available here.”

Deciphera specializes in developing cancer-fighting pharmaceuticals that use a technology called kinase inhibitors. Kinases are enzymes that transmit signals within cells to help the cells function. Kinase have “switch” mechanisms that allow the enzymes to “turn on” to perform its function, and “turn off” when not needed. Mutations in a kinase switch can cause a kinase to remain on continually, which can cause a cell to become cancerous. Kinase inhibitors work by targeting the faulty kinase switch, which cuts off the ability of tumor cells to thrive and spread.

“Our approach to cancer is not the standard chemotherapy, which is designed to kill any cell whether it is cancer or not,” Flynn said. “Kinase inhibiters are targeted therapeutics – they go into a cell and target the runaway kinase. The side-effect profile is much more favorable this way.”

Flynn said that Deciphera has spent the past five to six years focusing on researching and developing its specialized kinase inhibitor technology platform to produce drug candidates. It now has five drug candidates at various stages development that utilize the company’s technology. The ultimate goal is to advance these candidates into human clinical trials so that they may ultimately be available on the market to treat cancer patients. Clinical trials measure outcomes and assess the safety and effectiveness of a new drug or combination of drugs. New pharmaceuticals undergo three phases of clinical trials before being approved for marketing. Deciphera currently has three drug candidates in Phase I clinical trials, including one that is being developed in partnership with pharmaceutical giant Eli Lily.

Tech

Dechipera, front row left to right: Cynthia Leary, Anjanette Wilhelm & Daniel Flynn. Back row: Mike Kauffman, Bryan Smith, Linda Martin, Susan McElwain & John Lord

Flynn said that partnering with Eli Lily in the early stages of clinical trials was in Deciphera’s best interest for this particular drug. However, the company plans to conduct Phase I trials for its other drug platforms in its Lawrence labs when possible. It will then seek strategic partnerships with pharmaceutical companies once the drugs have advanced to later phases.

“Our design is to finish Phase I clinical trials in-house,” Flynn said. “It is all about risk and reward. If we have internal phase-one data that looks good, that leads to more favorable partnerships in the future.”

Deciphera recently hired Mike Taylor, a veteran of the bioscience deal-making industry, to serve as its new president and CEO. Taylor communes between Lawrence and Boston offices.

“It’s great to have him on board,” Flynn said. “He brings a good business acumen to the company.”

Deciphera currently has 16 total employees between the Lawrence and Boston offices. Although the company is currently focusing its attention on a few of its drug platforms, Flynn said that Deciphera has no shortage of other drugs with the potential to advance into clinical trials.

“We have a backlog of assets,” Flynn said. “Most companies our size have one or two assets, and they live or die based on those. We have a wealth of riches in our war chest.”

Where Deciphera uses its technology to create new drug formulations to fight cancer, CritiTech specializes in reformulating and improving pharmaceuticals that are already on the market. CritiTech is currently working on a reformulated version of the widely administered chemotherapy drug, Paclitaxel. The reformulated drug, which CritiTech has named Nanotax, performed favorably in a recent Phase I clinical trial focusing on ovarian cancer patients at the KU Medical Center.

CritiTech reformulates existing drugs using proprietary technology that transforms existing drug formulations into very fine particles. The core base of CritiTech’s technology was developed at KU by researcher, Bala Subramaniam, and CritiTech has continued to evolve and expand this technology, according to CritiTech President Matthew McClorey. Reformulating existing drugs into smaller particles can have a number of benefits, including making drugs less toxic, more effective and easier to administer.

Tech

President of CritiTech Matthew McClorey

McClorey said that CritiTech’s reformulation of Paclitaxel into Nanotax is an ideal example of what can be done with CritiTech’s technology. Paclitaxel is currently administered to ovarian cancer patients intravenously using a toxic delivery agent called Cremaphor. By reformulating Paclitaxel into smaller particles using its technology, CritiTech’s reformulated version, Nanotax, can be administered straight into the abdomen using water or saline.

“This is important because the Cremaphor creates significant toxicity for the patients. And because the Paclitaxel is administered into the vein, those toxic effects are systemic,” McClorey said. “The results of Nanotax Phase I trial indicated that it can be delivered at the site of the tumor, in a higher concentration, for a longer period of time, and without the typical side effects and toxicity that is associated with the drug that is currently on the market.”

McClorey said that CritiTech plans to move Nanotax forward in advanced clinical trials, and hopes the drug will be on the market in a few years. He also said that there is a good possibility that Nanotax will be applicable to other cancers including breast, liver and colorectal.

“We think we can improve the lives of ovarian cancer patients with this drug,” McClorey said. “We need to do expanded trials to prove that out, but that is why we are doing what we are doing – to improve the quality of life for these women and hopefully help them to live longer.”

With a solid example of what CritiTech’s technology can do well under way, the company is now starting to offer the technology’s service to other drug companies. Just as CritiTech developed a new and improved version of Paclitaxel, it wants to help other pharmaceutical companies.

“We have started providing this third-party drug development in this past year,” McClorey said. “We have had some contracts coming in from companies that are exploring the use of our technology as applied to the compounds that they are developing. Just like we developed a new and improved version of Paclitaxel, we want to help other pharmaceutical companies develop a new and improved version of their products.”

Share.

Related Posts

165 Comments

  2. insightfulpeek.com on

    After looking at a number of the blog articles on your blog, I really appreciate your technique of blogging. I bookmarked it to my bookmark website list and will be checking back soon. Please visit my website too and let me know your opinion.

  6. Seniors Medicaid and Medicare Benefits on

    Oh my goodness! Impressive article dude! Many thanks, However I am encountering troubles with your RSS. I don’t know why I cannot subscribe to it. Is there anybody else having the same RSS problems? Anyone who knows the answer will you kindly respond? Thanx!!

  7. Veterans Dependents Benefits on

    Right here is the perfect web site for everyone who would like to understand this topic. You realize so much its almost hard to argue with you (not that I actually would want to…HaHa). You certainly put a new spin on a topic which has been written about for ages. Wonderful stuff, just excellent.

  13. Curve finance on

    Can I simply say what a relief to discover somebody who really knows what they’re talking about on the web. You definitely know how to bring an issue to light and make it important. More people ought to look at this and understand this side of the story. I was surprised that you’re not more popular since you surely have the gift.

  17. Curve finance on

    Nhà cái uy tínBị ‘tố’ chậm bàn giao nhà, chủ đầu tư Discovery Complex 302 Cầu Giấy nói gì? Thời gian gần đây, thông tin về việc chủ đầu tư dự án Discovery Complex 302 Cầu Giấy bị tố chậm bàn giao nhà đã gây chú ý trong cộng đồng. Những phản ánh từ phía khách hàng cho rằng tiến độ không đảm bảo khiến nhiều người cảm thấy thất vọng. Phía chủ đầu tư đã lên tiếng giải thích rằng họ đang nỗ lực hết mình để hoàn thiện dự án, đồng thời cam kết sẽ sớm khắc phục các vấn đề và đáp ứng kỳ vọng của cư dân. Những câu chuyện cuộc sống đầy xúc động Côi cút 4 trẻ mồ côi bên bến đò Thạnh MỹTại một bến đò nhỏ ở Thạnh Mỹ, câu chuyện về 4 đứa trẻ mồ côi sống nương tựa vào nhau khiến bao người rơi nước mắt. Mất cha mẹ từ khi còn nhỏ, các em phải tự lo cho nhau trong hoàn cảnh khó khăn. «Hai đứa được đi học, mẹ chết cũng yên lòng…» là lời tâm sự nghẹn ngào của một trong những đứa trẻ, thể hiện khát vọng vươn lên dù cuộc sống đầy thách thức. Những chuyện tình đầy trăn trởCưới vội giờ muốn bỏ cho xong… Có những cặp đôi vì nhiều lý do mà kết hôn vội vã, để rồi sau đó nhận ra những khác biệt không thể hòa hợp. Hậu quả là những cuộc ly hôn đầy đau lòng, để lại bài học sâu sắc về sự thấu hiểu và cân nhắc kỹ trước khi bước vào cuộc sống hôn nhân. Đừng ngại khi yêu đàn ông lớn tuổi Tình yêu không phân biệt tuổi tác, và việc yêu một người đàn ông lớn tuổi đôi khi mang lại sự chín chắn, vững vàng mà không phải mối quan hệ nào cũng có được. Đừng ngần ngại nếu trái tim bạn hướng về một người trưởng thành, vì chính sự khác biệt này có thể là chìa khóa cho một mối quan hệ bền vững. Sức khỏe và những câu chuyện y họcĐã hoàn thiện phác đồ điều trị chuẩn cho bệnh nhân nhiễm Covid Trong cuộc chiến chống lại đại dịch Covid-19, các bác sĩ đã đạt được bước tiến lớn khi hoàn thiện phác đồ điều trị chuẩn. Điều này không chỉ giúp nâng cao tỷ lệ chữa khỏi bệnh mà còn mang lại hy vọng cho hàng triệu người dân trên toàn thế giới. Tán gia bại sản vì con mắc bệnh ung thư máu Một gia đình nghèo phải bán hết tài sản để chữa trị cho con bị ung thư máu. Sự hy sinh và tình yêu của cha mẹ dành cho con cái là điều không gì có thể đo đếm được, nhưng câu chuyện này cũng đặt ra câu hỏi lớn về việc hỗ trợ y tế cho những gia đình khó khăn. Những thông tin đáng chú ýThực hư thông tin VinFast tặng miễn phí 80 ô tô ‘made in Vietnam’ Thông tin về việc VinFast tặng miễn phí 80 chiếc ô tô «Made in Vietnam» cho người dùng đã gây xôn xao. Tuy nhiên, đại diện công ty cho biết đây là tin đồn không chính xác, đồng thời khuyến cáo người dân nên kiểm tra nguồn tin để tránh bị lừa đảo. Hà Nội khuyến khích doanh nghiệp phát triển sản phẩm công nghiệp chủ lực Thành phố Hà Nội đang đẩy mạnh khuyến khích các doanh nghiệp phát triển các sản phẩm công nghiệp chủ lực. Điều này không chỉ nâng cao sức cạnh tranh mà còn thể hiện sự xứng tầm của thủ đô trong lĩnh vực công nghiệp hiện đại. Cuộc sống đầy những câu chuyện, từ những khó khăn đến những bước tiến trong y học và công nghệ. Mỗi câu chuyện là một bài học, một góc nhìn để chúng ta thêm trân trọng và sống trọn vẹn hơn.

  22. DefiLlama Swap on

    Thanks for the sensible critique. Me and my neighbor were just preparing to do a little research about this. We got a grab a book from our area library but I think I learned more from this post. I’m very glad to see such excellent info being shared freely out there.

  27. ICSE Class12 on

    Your style is really unique in comparison to other folks I have read stuff from. Many thanks for posting when you have the opportunity, Guess I’ll just bookmark this site.

  46. blue salt trick on

    I was very happy to uncover this page. I want to to thank you for ones time for this wonderful read!! I definitely enjoyed every little bit of it and I have you book-marked to look at new information on your web site.

  50. Polygon Bridge on

    Heya i’m for the first time here. I came across this board and I find It truly useful & it helped me out a lot. I hope to give something back and help others like you helped me.

  55. good88b.org on

    You’ve made some good points there. I checked on the net for more information about the issue and found most individuals will go along with your views on this site.

  59. Classic Men’s Clothing on

    I’m more than happy to find this website. I wanted to thank you for your time for this particularly wonderful read!! I definitely really liked every bit of it and I have you book-marked to look at new things on your website.

  63. Menswear on

    Aw, this was an extremely good post. Taking the time and actual effort to generate a great article… but what can I say… I put things off a lot and never manage to get nearly anything done.

  65. Classic Men’s Clothing on

    Hello, I think your web site may be having browser compatibility issues. When I look at your website in Safari, it looks fine however when opening in IE, it has some overlapping issues. I merely wanted to give you a quick heads up! Other than that, great blog.

  70. download soundcloud songs on

    Aw, this was an incredibly nice post. Taking the time and actual effort to make a really good article… but what can I say… I procrastinate a whole lot and never manage to get nearly anything done.

  73. porn on

    Excellent post however I was wondering if you could write a litte more on this subject? I’d be very grateful if you could elaborate a little bit more. Thank you!|

  77. sexual on

    Hello there I am so thrilled I found your site, I really found you by accident, while I was looking on Google for something else, Anyhow I am here now and would just like to say thanks for a remarkable post and a all round thrilling blog (I also love the theme/design), I don’t have time to look over it all at the moment but I have book-marked it and also added in your RSS feeds, so when I have time I will be back to read much more, Please do keep up the great b.|

  78. đi tù on

    sex nhật hiếp dâm trẻ em ấu dâm buôn bán vũ khí ma túy bán súng sextoy chơi đĩ sex bạo lực sex học đường tội phạm tình dục chơi les đĩ đực người mẫu bán dâm

  83. nội tạng người on

    sex nhật hiếp dâm trẻ em ấu dâm buôn bán vũ khí ma túy bán súng sextoy chơi đĩ sex bạo lực sex học đường tội phạm tình dục chơi les đĩ đực người mẫu bán dâm

  101. skjldjl on

    Can I just say what a comfort to uncover someone that genuinely understands what they’re talking about online. You definitely realize how to bring a problem to light and make it important. More and more people really need to check this out and understand this side of the story. I was surprised you’re not more popular because you most certainly possess the gift.

  102. MCW Login on

    This site is known as a stroll-by way of for all of the data you wanted about this and didn?t know who to ask. Glimpse right here, and also you?ll positively uncover it.

  110. whatsapp苹果版 on

    Aw, this was a really nice post. Taking a few minutes and actual effort to create a superb article… but what can I say… I procrastinate a lot and don’t seem to get anything done.

  111. Valrie Chopton on

    Hi there! This article could not be written any better! Reading through this post reminds me of my previous roommate! He always kept talking about this. I’ll forward this information to him. Pretty sure he will have a good read. Many thanks for sharing!

  112. MCW Casino on

    Hello There. I found your blog using msn. This is an extremely well written article. I?ll make sure to bookmark it and return to read more of your useful info. Thanks for the post. I will certainly return.

  129. 新加坡国立大学 TELOGRAM @Lapsus$ on

    Today, I went to the beach front with my children. I found a sea shell and gave it to my 4 year old daughter and said “You can hear the ocean if you put this to your ear.” She placed the shell to her ear and screamed. There was a hermit crab inside and it pinched her ear. She never wants to go back! LoL I know this is entirely off topic but I had to tell someone!|

  134. damangames.cx/ on

    Thanks for one’s marvelous posting! I genuinely enjoyed reading it, you might be a great author.I will remember to bookmark your blog and will come back in the foreseeable future. I want to encourage you continue your great work, have a nice afternoon!|

  146. Russian Escorts in Mumbai on

    After I originally left a comment I seem to have clicked the -Notify me when new comments are added- checkbox and now whenever a comment is added I get four emails with the same comment. There has to be an easy method you are able to remove me from that service? Kudos.

  156. appliance man on

    After I initially left a comment I seem to have clicked on the -Notify me when new comments are added- checkbox and from now on every time a comment is added I recieve 4 emails with the same comment. Is there a means you can remove me from that service? Kudos.

  157. appliance repairs near me on

    I was extremely pleased to uncover this great site. I need to to thank you for ones time for this particularly fantastic read!! I definitely appreciated every part of it and i also have you saved to fav to check out new information on your site.

  161. 1xbet giriş on

    Hi, I do think this is an excellent blog. I stumbledupon it 😉 I will return once again since I book marked it. Money and freedom is the best way to change, may you be rich and continue to guide others.

  163. DefiLlama on

    Hey There. I found your blog using msn. This is a very well written article. I will be sure to bookmark it and come back to read more of your useful information. Thanks for the post. I will certainly comeback.

  165. 1xbet azerbaycan on

    Aw, this was an extremely nice post. Spending some time and actual effort to generate a top notch article… but what can I say… I procrastinate a whole lot and don’t seem to get nearly anything done.

Leave A Reply

Contact to Listing Owner

Captcha Code